Impact of newer direct-acting antiviral drugs based on quality-adjusted life years: A prospective pharmacoeconomic study in hepatitis C patients.

Vyas, Bhavya H; Darji, Nishita H; Rana, Devang A; Vyas, Kaushal Y; Malhotra, Supriya D

Vyas, Bhavya H; Darji, Nishita H; Rana, Devang A; Vyas, Kaushal Y; Malhotra, Supriya D.

Afiliación

Vyas BH; Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.
Darji NH; Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.
Rana DA; Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.
Vyas KY; Department of Gastroenterology, Seth V.S. Hospital, Ahmedabad, Gujarat, India.
Malhotra SD; Department of Pharmacology, Smt. NHL Municipal Medical College, Ahmedabad, Gujarat, India.

Perspect Clin Res ; 12(2): 76-82, 2021.

Article en En | MEDLINE | ID: mdl-34012903

Palabras clave

Hepatitis C; pharmacoeconomic; quality of life; quality-adjusted life years

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies Aspecto: Patient_preference Idioma: En Revista: Perspect Clin Res Año: 2021 Tipo del documento: Article País de afiliación: India Pais de publicación: India

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google